Toxicities and outcomes among septuagenarians and octogenarians with diffuse large B-cell lymphoma treated with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone therapy-Reference-Cited by-同舟云学术

Toxicities and outcomes among septuagenarians and octogenarians with diffuse large B-cell lymphoma treated with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone therapy

Published:2012-03 Issue:8 Volume:53 Page:1461-1468
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Huntington Scott F.,Talbott Mahsa S.,Greer John P.,Morgan David S.,Reddy Nishitha

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

http://www.tandfonline.com/doi/pdf/10.3109/10428194.2012.658793

Reference38 articles.

1. Epidemiology of non-Hodgkin?s lymphoma (NHL): trends, geographic distribution, and etiology

2. Comparison of a Standard Regimen (CHOP) with Three Intensive Chemotherapy Regimens for Advanced Non-Hodgkin's Lymphoma

3. Comparison of a Second-Generation Combination Chemotherapeutic Regimen (m-BACOD) with a Standard Regimen (CHOP) for Advanced Diffuse Non-Hodgkin's Lymphoma

4. CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-World Survival, Healthcare Resource Utilization, and Costs Among U.S. Elderly Patients With Diffuse Large B-Cell Lymphoma (DLBCL) Treated With R-GemOx in the Relapsed/Refractory Setting;Clinical Lymphoma Myeloma and Leukemia;2024-05

2. Oncologist volume and outcomes in older adults diagnosed with diffuse large B cell lymphoma;Cancer;2018-09-14

3. Combination of rituximab and nonpegylated liposomal doxorubicin (R-NPLD) as front-line therapy for aggressive non-Hodgkin lymphoma (NHL) in patients 80 years of age or older: a single-center retrospective study;Hematological Oncology;2017-02-03

4. Split-dose R-CHOP: a new approach to administer cytotoxic chemo-immunotherapy to elderly patients with DLBCL;The Journal of Community and Supportive Oncology;2016-11

5. Reduced Dose Intensities of Doxorubicin in Elderly Patients with DLBCL in Rituximab Era;Cancer Research and Treatment;2016-01-15